Orion OYJ (OTCMKTS:ORINY) Shares Gap Up – Still a Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price gapped up before the market opened on Monday . The stock had previously closed at $38.92, but opened at $42.09. Orion OYJ shares last traded at $42.09, with a volume of 260 shares trading hands.

Orion OYJ Stock Up 8.1%

The stock has a market cap of $11.88 billion, a PE ratio of 17.32 and a beta of 0.08. The business has a fifty day moving average of $38.42 and a 200-day moving average of $38.73. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.77 and a quick ratio of 1.13.

Orion OYJ (OTCMKTS:ORINY) last released its quarterly earnings data on Friday, July 17th. The company reported $0.58 EPS for the quarter. The company had revenue of $606.38 million for the quarter. Orion OYJ had a return on equity of 51.86% and a net margin of 28.52%.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.